Blood Preparation Market Size, Share & Trends Report

Blood Preparation Market Size, Share & Trends Analysis Report By Product (Whole Blood, Blood Components, Blood Derivatives), Antithrombotic And Anticoagulants Type, By Application, And Segment Forecasts, 2019 - 2026

  • Published Date: Apr, 2019
  • Base Year for Estimate: 2018
  • Report ID: 978-1-68038-455-0
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2017
  • Number of Pages: 110

Industry Insights

The global blood preparation market size was valued at USD 36.7 billion in 2018and is projected to expand at a CAGR of 5.6% from 2019 to 2026. Growing demand for blood and its components in surgical procedures is expected to be a key factor driving the market. According to the Healthcare Cost and Utilization Project (HCUP) Statistical Briefs, blood transfusion was the most common procedure performed during hospitalizations for the period from 2006 to 2015 in U.S.

Some biopharmaceutical companies are financing resources for the development of new drugs. Organizations, such as the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), are taking initiatives for raising awareness levels via programs that aim to prevent thrombosis-associated complications in early stages. In addition, growing geriatric population base and rising healthcare expenditures are likely to boost the market further.

U.S. blood preparation market

The introduction of novel technologies along with the increasing usage of plasma in pharmaceutical industry are further projected to contribute to the market growth over the forecast period. Various governments across the globe are focusing on increasing the number of blood donations by applying reimbursement policies, such as monetary incentives for donors. This factor is also expected to help augment the growth of the global market over the next few years.

Based on regional markets, North America is projected to be the largest market while APAC is expected to register the fastest growth during the forecast years. The growth of APAC region can be attributed to the presence of sophisticated healthcare infrastructure, especially in Japan and Australia. Moreover, favorable government initiatives and several untapped opportunities in the emerging markets of China and India will drive the regional market further.

Product Insights

Based on product, the blood preparation market is segmented into whole blood, derivatives, and components. Whole blood product segment held the largest market share in 2018. Increasing demand for whole blood for major surgeries and transfusions along with its advantages, such as easy availability, low cost, and maintenance, is the major factor contributing to the segment’s high share.

On the other hand, blood derivatives is likely to be the fastest-growing segment over the forecast years. Presence of government initiatives for the development of plasma-derived proteins, such as immunoglobulins, coagulation factor products, human fibrin foam, dried human plasma, and human thrombin, are expected to drive market growth.

Blood derivatives, such as intravenous immunoglobulin and hyperimmune, are used to boost immunity in cases of life-threatening infections, such as Ebola. Increasing prevalence of such diseases, introduction of advanced technologies to separate the components, and launch of blood-derived medicines are the factors anticipated to boost the segment growth.

Antithrombotic and Anticoagulants Type Insights

The antithrombotic and anticoagulants market is categorized on the basis of type into platelet aggregation inhibitors, fibrinolytics, and anticoagulants. Among these, anticoagulants led the type segment in 2018 and is expected to register a lucrative CAGR from 2019 to 2026. This growth is attributed to the introduction of new products with higher efficacy and the potential commercialization of new products currently in the pipeline.

Biopharmaceutical companies are upgrading their products by launching novel and more efficient anticoagulant drugs in the market. Re-launch of some key drug products, such as Urokinase in North America, is expected to fuel its growth in the coming years. Anticoagulant drugs include heparins, vitamin K antagonists, direct thrombin inhibitors, and direct factor Xa inhibitors.

Antithrombotic and Anticoagulants Application Insights

Based on the application, the market has been segmented into thrombocytosis, pulmonary embolism, renal impairment, angina blood vessel complications, and others. Among these, antithrombotic products are widely used in thrombocytosis. Higher platelet count leads to coagulation of blood in the circulatory system, which ultimately causes life-threatening heart conditions. Thrombocytosis is classified as primary and secondary. Primary thrombocytosis is uncommon affecting around 24 individuals per million globally. It is prevalent in middle-aged people and in women below 40 years. Secondary thrombocytosis is more common due to the conditions, such as hyposplenism, splenectomy, asplenia, hemorrhage, osteosarcoma, and rheumatoid arthritis.

Global antithrombotic and anticoagulants market

Angina blood vessel complications are expected to grow at the fastest CAGR during the forecast period owing to rising R&D for the development of anticoagulants for cardiac problems and increasing prevalence of Cardiovascular Disorders (CVDs). Angina pectoris is characterized by severe pain in the chest and discomfort owing to insufficient oxygen supply to the heart. Although the main treatment for angina is nitroglycerine, use of anticoagulants is significant owing to the frequency of complications in the former. Furthermore, rise in lifestyle-associated diseases, popularity of oral anticoagulants, growing patient awareness, increased healthcare expenditure, and favorable government policies are the factors driving the segment.

Regional Insights

North America led the overall market in terms of revenue in 2018 owing to high incidence of CVDs, leukemia, and hematological and neurological diseases in the region. Higher patient awareness and healthcare expenditure levels along with the presence of sophisticated healthcare infrastructure will boost the region’s growth further. Asia Pacific is expected to witness the fastest growth on account of improving healthcare infrastructure, presence of untapped opportunities, economic development, and rising initiatives by private and public organizations.

Blood Preparation Market Share Insights

Key companies in the market are AstraZeneca PLC; Sanofi S.A.; LEO Pharma A/S; Bristol-Myers Squibb Company; Baxter International, Inc.; Pfizer, Inc.; Portola Pharmaceuticals, Inc.; and GlaxoSmithKline PLC. Most of the companies have adopted strategies, such as new product launches, mergers and acquisition, and collaborations, to increase their market share. For instance, in June 2017, Portola Pharmaceuticals, Inc. received FDA approval for the commercial launch of Bevyxxa, a novel oral anticoagulant drug.

Report Scope

Attribute

Details

Base year for estimation

2018

Actual estimates/Historical data

2014 - 2017

Forecast period

2019 - 2026

Market representation

Revenue in USD Million and CAGR from 2019 to 2026

Regional scope

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Country scope

U.S., Canada, U.K., Germany, Spain, France, Italy, Russia, China, Japan, India, South Korea, Singapore, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, and UAE

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

15% free customization scope (equivalent to 5-analyst working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments Covered in the Report

This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2026. For the purpose of this study, Grand View Research has segmented the global blood preparation market report on the basis of product, type, application, and region:

  • Product Outlook (Revenue, USD Million, 2014 - 2026)

    • Whole Blood

      • Red Cells

      • Granulocytes

      • Plasma

      • Platelets

    • Blood Components

      • Whole Blood Components

      • Packed Red Cells

      • Leukocyte Reduced Red Blood Cells

      • Frozen Plasma

      • Platelet Concentrate

      • Cryoprecipitate

    • Blood Derivatives

  • Antithrombotic and Anticoagulants Type Outlook (Revenue, USD Million, 2014 - 2026)

    • Platelet Aggregation Inhibitors

      • Glycoprotein Inhibitors

      • COX Inhibitors

      • ADP Antagonists

      • Others

    • Fibrinolytics

      • Tissue Plasminogen Activator (tPA)

      • Streptokinase

      • Urokinase

    • Anticoagulants

      • Heparins

        • Unfractionated Heparin

        • Low Molecular Weight Heparin (LMWH)

        • Ultra-low Molecular Weight Heparin

      • Vitamin K Antagonists

      • Direct Thrombin Inhibitors

      • Direct Factor Xa Inhibitors

  • Antithrombotic and Anticoagulants Application Outlook (Revenue, USD Million, 2014 - 2026)

    • Thrombocytosis

    • Pulmonary Embolism

    • Renal Impairment

    • Angina Blood Vessel Complications

    • Others

  • Regional Outlook (Revenue, USD Million, 2014 - 2026)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • Spain

      • France

      • Italy

      • Russia

    • Asia Pacific

      • China

      • Japan

      • India

      • Australia

      • South Korea

      • Singapore

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,950
Multi User (2-5) - $5,950
Enterprise Access - $7,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified